DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Unichem Laboratories Limited — Action(s) taken or orders passed

NSE 1 hr ago·19 Sept 2026, 6:00 am

Unichem Laboratories

Unichem Laboratories has informed stock exchanges that regulatory authorities have taken action or passed orders against the company. The specific nature of these orders or actions remains undisclosed in the public announcement.

This development is significant for investors as it signals that the company is facing regulatory scrutiny. While the details are not yet clear, such actions can sometimes impact a company's reputation, operational flexibility, or financial standing, necessitating a careful review of the situation.

Investors should wait for the company to provide further details regarding the orders. Monitoring the stock's reaction and any subsequent clarifications from management will be crucial to understanding the potential impact on the business.